Gene Expression Reagents Markets

Table of Contents

1. Overview

• 1.1Objectives of the Report
• 1.2Methodology
• 1.3Scope of the Report
• 1.4Executive Summary

2. Gene Expression

• 2.1The Genomics Revolution
• 2.2Basic Principles of Gene Expression
  • 2.3.1Quantitative Real-Time PCR (qRT-PCR)
  • 2.3.2PCR Labeling Chemistries
  • 2.3.3TaqMan® Probes
  • 2.3.4SYBR® Green
• 2.4Microarray Technology
• 2.5Microarray Target Preparation and Hybridization
• 2.6RNA Sample Preparation and Assessment

3. Gene Expression Reagents

• 3.1Kit Format vs. Home-Brew Assays
• 3.2Whole Product Solutions
• 3.3Emerging Technologies

4. Market Environment

• 4.1Institutional and Government Budgeting
• 4.2Worldwide Investment in Genomics Technologies and Research
• 4.3Industry Consolidation and Acquisitions

5. Market Drivers

• 5.1Improved Assay Performance
• 5.2Cost Effective Systems
• 5.3Automation
• 5.4Bioinformatics Solutions

6. Worldwide Market for Gene Expression Reagents

• 6.1Life Science Research
• 6.2Drug Discovery and Development, Molecular Diagnostics
• 6.3Commercial Production
• 6.4Gene Expression Market Size
  • 6.4.1Real-Time PCR Revenue
  • 6.4.2Commercial Microarray Revenue
  • 6.4.3RNA Sample Preparation Revenue
• 6.5Gene Expression Reagent Market by Region
• 6.6Users of Gene Expression Products
  • 6.6.1Core Laboratories
  • 6.6.2Consortia
  • 6.6.3Pharmaceutical and Biotechnology Companies
• 6.7Affiliation
• 6.8Job Function and Decision Makers

7. Key Applications

• 7.1BioMarker Identification and Pharmacogenomics
• 7.2Toxicogenomics
• 7.3Molecular Diagnostics

8. Vendor and Product Selection

• 8.1Product Adoption
• 8.2Drivers for Product Switching

9. Leading Vendors

10. Marketing Strategies

• 10.1e-Marketing and e-Commerce
• 10.2Catalog
• 10.3On-Site Cabinet Programs

11. Pricing Strategies

• 11.1Price Elasticity
• 11.2Strategies

12. Distribution Channels

13. Competitive Situation

14. Opportunities

15. Market Strategy Profiles, Leading and Selected Vendors

• 15.1Applied Biosystems
  • 15.1.1Applera Corporation-Corporate History and Structure
  • 15.1.2Molecular Biology Technology and Products
  • 15.1.3Acquisitions, Partnerships and Collaborations, 2006
  • 15.1.4Product Portfolio Summary
  • 15.1.5Real-Time PCR/Genomics Products and Consumables
  • 15.1.6Real-Time PCR/Genomics New Product Introductions, 2006
  • 15.1.7End-Users
  • 15.1.8Distribution Channels
  • 15.1.9Competition-Gene Expression Products
  • 15.1.10Competitive Analysis
  • 15.1.11Business Model
• 15.2Affymetrix
  • 15.2.1Corporate History and Structure
  • 15.2.2Technology
  • 15.2.3Partnerships and Collaborations
  • 15.2.4Product Portfolio Summary
  • 15.2.5Complementary Services
  • 15.2.6New Product Introductions
  • 15.2.7End-Users
  • 15.2.8Distribution Channels
  • 15.2.9Competition
  • 15.2.10Competitive Analysis
  • 15.2.11Business Model
• 15.3Invitrogen
  • 15.3.1Corporate History and Structure
  • 15.3.2Technology
  • 15.3.3Acquisitions
  • 15.3.4Partnerships and Collaborations
  • 15.3.5Product Profile Summary
  • 15.3.6Gene Expression Product Portfolio
  • 15.3.7New Product Introductions
  • 15.3.8End-Users
  • 15.3.9Distribution Channels
  • 15.3.10Competition
  • 15.3.11Competitive Analysis
  • 15.3.12Business Model
• 15.4Qiagen
  • 15.4.1Corporate History and Structure
  • 15.4.2Technology
  • 15.4.3Acquisitions, Partnerships and Collaborations
  • 15.4.4Collaborations and Partnerships
  • 15.4.5Product Portfolio Summary
  • 15.4.6Complementary Services
  • 15.4.7New Product Introductions
  • 15.4.8End-Users
  • 15.4.9Distribution Channels
  • 15.4.10Competition
  • 15.4.11Competitive Analysis
  • 15.4.12Business Model
• 15.5GE Healthcare (Formerly Amersham Biosciences)
  • 15.5.1Corporate History and Structure
  • 15.5.2Technology
  • 15.5.3Product Portfolio Summary
  • 15.5.4Complementary Services
  • 15.5.5Genomics New Product Introductions
  • 15.5.6Amersham Biosciences End-Users
  • 15.5.7Distribution Channels
  • 15.5.8Competition
  • 15.5.9Competitive Analysis
  • 15.5.10Business Model
• 15.6Stratagene
  • 15.6.1Corporate History and Structure
  • 15.6.2Technology
  • 15.6.3Acquisitions, Collaborations, Alliances and Partnerships
  • 15.6.4Product Portfolio Summary-Research Products Division
  • 15.6.5New Product Introductions
  • 15.6.6Complementary Services
  • 15.6.7End-Users
  • 15.6.8Distribution Channels
  • 15.6.9Competition
  • 15.6.10Competitive Analysis
  • 15.6.11Business Model

Appendix I: Leading Vendor' s Gene Expression Products

Appendix II: Gene Expression Product Groups

Appendix III: Companies Offering Gene Expression Products

LIST OF FIGURES

• Figure 2.1: Gene Expression Process
• Figure 2.2: qRT-PCR Workflow
• Figure 2.3: Microarray Workflow
• Figure 6.1: Gene Expression Market by Region
• Figure 6.2: Researchers Using Gene Expression Technologies Worldwide, 2005
• Figure 6.3: Distribution of Laboratory Workers by Organization in North America
• Figure 6.4: Laboratory Job Function
• Figure 6.5: Product Selection and Purchasing Decision Makers

LIST OF TABLES

• Table 5.1: Microarray Analysis Cost per Sample
• Table 5.2: Cost of qRT-PCR Research Reagents and Systems
• Table 6.1: Five-Year Forecast-Gene Expression Reagents, Instruments
• Table 6.2: RNA Sample Preparation Revenue
• Table 6.3: Forecasted Annual Revenue-qRT-PCR, 2005-2010
• Table 6.4: Forecasted Annual Revenue-Commercial Microarrays, Reagents, Instruments, 2005-2010
• Table 6.5: Forecasted Annual Revenue-Gene Expression Reagents, Instruments, 2005-2010
• Table 6.6: Forecasted Annual Revenue-RNA Sample Preparation, 2005-2010
• Table 6.7: Projected Revenue Growth of Microarrays and Related Products
• Table 6.8: Major Players' Distribution of Revenue by Region, 2005
• Table 6.9: Decision Makers Profile
• Table 9.1: Major Vendors-Gene Expression Reagents and RNA Sample Preparation
• Table 9.2: Vendors' Key Statistics, 2005
• Table 9.3: Vendors' Technology and Products
• Table 11.1: RNA Sample Preparation-Vendors Prices
• Table 11.2: qPCR Kits-Vendor' s Prices
• Table 11.3: Reverse Transcriptase-Vendor' s Prices
• Table 12.1: Distribution Channels
• Table 15.1: Applied Biosystems Revenue, 2005
• Table 15.2: Affymetrix Revenue, 2005
• Table 15.3: Invitrogen Revenue, 2005
• Table 15.4: Qiagen Revenue, 2005
• Table 15.5: GE Healthcare Revenue, 2005
• Table 15.6: Stratagene Revenue, 2005